Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival
Y Hisada, N Mackman - Current opinion in hematology, 2019 - journals.lww.com
Y Hisada, N Mackman
Current opinion in hematology, 2019•journals.lww.comCancer cell-derived tissue factor-positive extracellular ves... : Current Opinion in Hematology
Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and
survival : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
September 2019 - Volume 26 - Issue 5 Previous Article Next Article HEMOSTASIS AND …
Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and
survival : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
September 2019 - Volume 26 - Issue 5 Previous Article Next Article HEMOSTASIS AND …
Summary
Cancer cell-derived TF+ EVs bind to and activate endothelial cells. In addition, they serve as biomarkers of survival of cancer patients and venous thrombosis in pancreatic cancer patients.
Lippincott Williams & Wilkins